References
- Anderson , J. and Doyal , L. 2004 . Women from Africa living with HIV in London: a descriptive study . AIDS Care , 16 : 95 – 105 .
- Barret , B. , Tardieu , M. Rustin , P. 2003 . Persistent mitochondrial dysfunction in HIV-1-exposed but uninfected infants: clinical screening in a large prospective cohort . AIDS , 17 : 1769 – 85 .
- Blanche , S. , Tardieu , M. Rustin , P. 1999 . Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues . Lancet , 354 : 1084 – 89 .
- Brogly , S. , Williams , P. Seage , G.R. 2006 . In utero nucleoside reverse transcriptase inhibitor exposure and cancer in HIV-uninfected children: an update from the Pediatric AIDS Clinical Trials Group 219 and 219C cohorts . Journal of Acquired Immune Deficiency Syndromes , 41 : 535 – 36 .
- Connor , E.M. , Sperling , R.S. Gelber , R. 1994 . Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group . New England Journal of Medicine , 331 : 1173 – 80 .
- Cooper , E.R. , Charurat , M. Mofenson , L. 2002 . Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission . Journal of Acquired Immune Deficiency Syndromes , 29 : 484 – 94 .
- Culnane , M. , Fowler , M.G. Lee , S.S. 1999 . Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women . Journal of the American Medical Association , 281 : 151 – 57 .
- European Collaborative Study . 2005 . Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy . Clinical Infectious Diseases , 40 : 458 – 65 .
- Hankin , C.D. , Tookey , P.A. Lyall , E.G.H. 2004 . Follow up of children exposed to antiretroviral therapy in pregnancy (CHART). Royal College of Paediatrics and Child Health 8th Spring Meeting, York, UK, 2004 . Archives of Disease in Childhood , 89 ( Suppl 1 ) : A76
- Hawkins , D. , Blott , M. Clayden , P. 2005 . Guidelines for the management of HIV infection in pregnant women and the prevention of mother-to-child transmission of HIV . HIV Medicine , 6 ( Suppl 2 ) : 107 – 48 .
- Lee , M.B. and Rotheram-Borus , M.J. 2002 . Parents’ disclosure of HIV to their children . AIDS , 16 : 2201 – 07 .
- Mofenson , L.M. and Munderi , P. 2002 . Safety of antiretroviral prophylaxis of perinatal transmission for HIV-infected pregnant women and their infants . Journal of Acquired Immune Deficiency Syndromes , 30 : 200 – 15 .
- Olivero , O.A. , Anderson , L.M. Diwan , B.A. 1997 . Transplacental effects of 3′-azido-2′,3′-dideoxythymidine (AZT): tumorigenicity in mice and genotoxicity in mice and monkeys . Journal of the National Cancer Institute , 89 : 1602 – 08 .
- Thorne , C. and Newell , M.L. 2005 . The safety of antiretroviral drugs in pregnancy . Expert Opinion on Drug Safety , 4 : 323 – 35 .
- Townsend , C.L. , Tookey , P.A. Cortina-Borja , M. 2006 . Antiretroviral therapy and congenital abnormalities in infants born to HIV-1-infected women in the United Kingdom and Ireland, 1990 to 2003 . Journal of Acquired Immune Deficiency Syndromes , 42 : 91 – 94 .
- Vallerand , A.H. , Hough , E. Pittiglio , L. 2005 . The process of disclosing HIV serostatus between HIV-positive mothers and their HIV-negative children . AIDS Patient Care and STDs , 19 : 100 – 09 .